Health Library › Tests › Reticulocyte count
Test
A reticulocyte count measures young red blood cells to assess bone marrow activity
A reticulocyte count measures the number of reticulocytes in your blood. Reticulocytes are young red blood cells that have recently left the bone marrow, the soft tissue inside bones where blood cells are made.
Reticulocytes mature into adult red blood cells within about one or two days after entering the bloodstream. Measuring them gives a snapshot of how actively your bone marrow is producing red blood cells.
The test is commonly used when a complete blood count, or CBC, shows anemia. Anemia means you do not have enough red blood cells or hemoglobin to carry oxygen normally. A reticulocyte count can help show whether the bone marrow is responding appropriately.
The result does not identify the cause by itself. It is interpreted with your hemoglobin, red blood cell count, blood cell size, symptoms, medical history, and other tests.
A reticulocyte count can help distinguish between broad causes of anemia.
If reticulocyte production is increased, the marrow may be replacing red blood cells that were recently lost or destroyed. If production is low or not high enough for the degree of anemia, the marrow may lack necessary nutrients, receive too little stimulation, or be affected by illness or treatment.
The test may be ordered to:
The kidneys make erythropoietin, a hormone that tells the bone marrow to produce red blood cells. Reduced kidney function can therefore affect reticulocyte production.
A reticulocyte count is not usually used as a general screening test on its own. It is most useful when another blood result, your symptoms, or your medical history raises a question about red blood cell production.
Your healthcare professional may order it if you have anemia, unexplained changes in hemoglobin, suspected blood loss, or possible hemolysis. Hemolysis means red blood cells are being destroyed faster than usual.
It may also be used during treatment for a nutrient deficiency, kidney disease, cancer, or a bone marrow condition. In newborns and children, the reason for testing and the expected result can differ from those in adults.
You usually do not need to fast. You can normally eat, drink water, and take your usual medicines before the blood draw.
If other blood tests are being collected at the same time, their preparation rules may be different. For example, another test may require fasting even though the reticulocyte count does not.
Tell the person who ordered the test about recent blood transfusions, bleeding, chemotherapy, vitamin or iron treatment, and medicines that affect blood cell production. Do not stop a prescribed medicine unless you have been told to do so.
A healthcare professional takes a small blood sample from a vein, usually in your arm. A band may be placed around your upper arm, and the skin is cleaned before a needle is inserted.
The collection usually takes a few minutes. You may feel a brief scratch or sting.
For babies, blood may sometimes be collected with a heel prick. The laboratory then measures reticulocytes, usually with an automated blood cell analyzer.
Results may be reported as a percentage or as an absolute reticulocyte count.
The percentage shows how many of your red blood cells are reticulocytes. The absolute count estimates the actual number of reticulocytes in a set volume of blood. The absolute count is often more useful when the total number of red blood cells is unusually low or high.
Some reports also include an immature reticulocyte fraction. This measures the youngest reticulocytes and may help show early changes in marrow activity. A corrected reticulocyte percentage or reticulocyte production index may be calculated when anemia is present.
A higher result may mean the bone marrow is responding to:
A low result, or one that is not appropriately increased during anemia, may occur when red blood cell production is reduced. Possible reasons include nutrient deficiency, reduced erythropoietin from kidney disease, bone marrow disorders, chronic illness, chemotherapy, or certain medicines.
Neither a high nor a low result establishes a diagnosis. Reference ranges and interpretation vary by laboratory, age, sex, pregnancy status, medicines, and clinical context. Newborns may have different expected values from older children and adults.
The reticulocyte percentage can be misleading when the total red blood cell count changes. In anemia, a seemingly normal or high percentage may still represent an inadequate marrow response. An absolute or corrected count can give a clearer picture.
Several factors can change the result without indicating a new bone marrow problem:
Timing matters. After sudden bleeding or red blood cell destruction, the reticulocyte count may not rise immediately. Testing very early can therefore look less responsive than a later test.
Sample age and analyzer-related interference can also affect measurement. If the result does not fit the rest of the blood count, the laboratory may review a blood smear or repeat the test.
Automated reticulocyte counting is generally more precise than counting the cells by hand under a microscope. However, the result still needs clinical context.
The test can miss an active marrow response if it is performed before enough new cells have entered the bloodstream. It can also appear reassuring when only the percentage is considered in someone with significant anemia.
Occasionally, unusual blood cells, cell fragments, or staining interference can be mistaken for reticulocytes or prevent accurate classification. Modern analyzers often flag these samples for review, but they cannot eliminate every error.
A reticulocyte count shows whether the marrow is releasing young red blood cells. It does not directly reveal why production is increased or reduced. Depending on the question, more useful tests may include iron studies, vitamin B12 and folate levels, kidney and liver tests, markers of hemolysis, a blood smear, or tests for bleeding.
If blood counts remain unexplained or several blood cell types are affected, specialized testing may be needed. In selected cases, examination of bone marrow provides information that a reticulocyte count cannot.
The risks are those of a routine blood draw. You may have brief discomfort, a small bruise, or feel lightheaded.
Pressure over the needle site usually stops minor bleeding. Serious complications are uncommon.
Your result is usually reviewed alongside your CBC and the reason the test was ordered. A single abnormal result often leads to routine follow-up, such as repeat blood counts or tests for iron deficiency, vitamin deficiency, kidney function, bleeding, or red blood cell destruction.
During treatment, a rising reticulocyte count may be an early sign that the marrow is responding. The expected timing differs according to the cause and treatment, so the trend may be more informative than one measurement.
An abnormal reticulocyte count alone is not usually an emergency. Arrange routine follow-up to discuss what the result means in your situation.
Seek urgent medical care if you have heavy or uncontrolled bleeding, fainting, severe shortness of breath, new chest pain, confusion, or rapidly worsening weakness. These symptoms require assessment regardless of the reticulocyte result.
Can I drink coffee before a reticulocyte count?
Yes. Coffee does not usually affect the test, and fasting is not required. If other tests are being collected, follow their instructions.
Does the time of day matter?
Usually not. The test can generally be collected at any time, although repeat tests may be scheduled consistently to make trends easier to compare.
Can I exercise beforehand?
Ordinary activity is unlikely to meaningfully change the result. Strenuous exercise can affect several blood measurements through fluid shifts, so mention unusual or intense exercise if a result is unexpected.
Is a reticulocyte count part of a CBC?
Not always. It uses the same type of blood sample but often needs to be ordered separately. Some laboratories may report related reticulocyte measurements together.
Does a high count mean I have a bone marrow disease?
Not necessarily. A high count often shows that the marrow is responding to blood loss, red blood cell destruction, or treatment. Other results are needed to find the reason.
How soon can the test show that anemia treatment is working?
Reticulocytes can change before hemoglobin does, but timing varies with the cause, treatment, and marrow health. Your healthcare professional may compare several results rather than rely on one test.
sofidex [Internet]. Daloreum; c2026. Reticulocyte count; [reviewed 2026 Aug 24; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/tests/reticulocyte-count
sofidex. (2026, August 24). Reticulocyte count. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/tests/reticulocyte-count
Reticulocyte count. sofidex. Reviewed August 24, 2026. Accessed November 10, 2026. https://sofidex.com/patients/tests/reticulocyte-count
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.